Want to test for COVID but think you need special equipment?
Accurate results in minutes — just “sample, dip and read”
Reliable, accessible and frequent SARS-CoV-2 rapid testing with Sofia®
Automated and objective results in 15 minutes at the point-of-care
To defeat the virus, you must first know where it is.
Our proprietary tracking and mapping system for COVID-19, Flu, RSV, and more.
Lyra® and Lyra Direct Assays –
Our time-saving, high-throughput, high-quality molecular tests for the detection of COVID-19.
Find out more
COVID-19 can have a significant impact on the Cardiovascular System.
SARS-CoV-2 has been associated with acute and long-term cardiovascular complications.
Revolutionizing medical diagnostics, from cell culture to immunoassays to molecular diagnostics, built for a pandemic, Quidel continues to expand on Point-of-Care (POC) testing solutions to address the needs of physicians and laboratorians globally.
BRING BACK
THE MORNING BELL
Keep your students and teachers in the classroom with affordable COVID-19 testing.
Providing schools with confidence to bring students and staff safely back to campus.
Quidel can help learning institutions develop affordable COVID-19 screening solutions from our catalog of rapid testing products.
BRING ON
BUSINESS AS USUAL
Help your employees return to work confidently and comfortably with COVID-19 testing.
Working with businesses to keep their employees healthy and in the workplace.
From on-site testing to same day results and reporting, Quidel can customize an end-to-end testing solution to meet your corporation’s needs.
Why Lyme disease could be worse this year.
Ticks don’t know the meaning of “Social Distancing.”
With “normal” activities limited, more families will take to the outdoors, the only thing, ticks don’t play by our rules, so Lyme disease could end up on the rise.
COVID-19 related hospitalizations could bring C. difficile.
An influx of COVID-19 related hospitalizations brings patients presenting a spectra of symptoms, requiring a spectra of treatments – this convergence could lead to an increased risk of C.difficile.
C. difficile could be coming in
with your COVID patients.
From cell culture to immunoassays to molecular diagnostics, Quidel continues to expand on Point-of-Care (POC) testing solutions to address the needs of physicians and laboratorians globally.